Campbell & Co Investment Adviser’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
+45,378
New +$1.05M 0.06% 508
2026
Q1
– Sell
-120,585
Closed -$2.73M – 1159
2025
Q4
$2.73M Buy
+120,585
New +$2.62M 0.13% 241
2024
Q4
– Sell
-30,699
Closed -$451K – 1130
2024
Q3
$451K Buy
+30,699
New +$428K 0.03% 756
2023
Q3
– Sell
-58,629
Closed -$590K – 1010
2023
Q2
$590K Buy
+58,629
New +$544K 0.11% 347
2022
Q2
– Sell
-13,232
Closed -$345K – 735
2022
Q1
$345K Buy
13,232
+4,632
+54% +$123K 0.09% 425
2021
Q4
$244K Buy
+8,600
New +$267K 0.08% 453
2021
Q3
– Sell
-7,200
Closed -$250K – 635
2021
Q2
$250K Buy
+7,200
New +$237K 0.1% 379

Other funds holding ELAN

Campbell & Co Investment Adviser's ELAN Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Elanco Animal Health (ELAN) in Q2 2026: 45,378 shares worth $1.12M. The stake represents 0.06% of the portfolio and ranks #508 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in ELAN as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in ELAN in Q2 2021 and has held it in 7 quarters since. The position peaked at $2.73M in Q4 2025. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Campbell & Co Investment Adviser held 45,378 shares of Elanco Animal Health worth $1.12M as of Q2 2026.
  • Elanco Animal Health was a new Campbell & Co Investment Adviser position in Q2 2026.
  • Elanco Animal Health made up 0.06% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #508 holding.
  • Campbell & Co Investment Adviser first reported a position in Elanco Animal Health in Q2 2021 and has held it in 7 quarters since.
  • Campbell & Co Investment Adviser's Elanco Animal Health position peaked at $2.73M in Q4 2025.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.